Target intelligence / Profile preview

Gastrointestinal luminal gas

Molecular classification
Other
01

Overview

Gastrointestinal luminal gas is a complex mixture of gases—predominantly nitrogen, hydrogen, carbon dioxide, methane, and oxygen—found within the digestive tract (StatPearls, 2023). These gases are produced through several mechanisms, including aerophagia (swallowing air), intraluminal chemical reactions, and the metabolic activity of the gut microbiota during the fermentation of dietary fibers (PubMed, PMID: 30060924). In healthy individuals, gas volume is regulated through eructation, absorption into the bloodstream, and flatulence; however, dysregulation or excessive production is a hallmark of functional gastrointestinal disorders like irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO) (NIH, 2022). Pharmacological management often targets the physical state of these gases; for instance, simethicone acts as a surfactant to reduce the surface tension of small gas bubbles, allowing them to merge into larger bubbles that are more easily expelled (NCBI, NBK555931). Other therapeutic approaches include the use of enzymes like alpha-galactosidase to prevent gas formation by breaking down non-digestible oligosaccharides before they reach gas-producing colonic bacteria (PubMed, PMID: 17151807).

Other names
Intestinal gasFlatusBowel gasGI gasAbdominal gas
02

Mechanism of action

Reduction of surface tension of gas bubbles to facilitate coalescence and expulsion (anti-foaming agent) or enzymatic degradation of gas-producing substrates.

03

Biological functions

Metabolic byproductFermentation productDigestion byproduct
04

Disease associations

FlatulenceAbdominal bloatingIrritable bowel syndromeSmall intestinal bacterial overgrowthFunctional dyspepsia
05

Safety considerations

Masking of underlying gastrointestinal obstructionReduced absorption of other medications
06

Interacting drugs

Simethicone

3 more in the full profile.

07

Biomarkers

Hydrogen breath testMethane breath test

Beyond the preview

Go deeper on Gastrointestinal luminal gas.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal luminal gas.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call